To determine the fraction of tumor cells expressing BCMA, tissues were also stained for CD138 (multiple myeloma), IgM (LPL), cyclin D1 (MCL), and Pax-5 (CLL and DLBCL; Fig. 3A). This evidence concerns the gene TNFRSF17 and neoplasm.